{
    "nctId": "NCT00752310",
    "title": "A Phase I, Open-label, Randomized, Crossover Trial in Healthy Subjects Receiving DRV Combined With RTV Low Dose to Compare the Oral Bioavailability of DRV Suspension to That of DRV 300 mg Tablet Under Fasted and Fed Conditions, and to Assess Multiple Dose Pharmacokinetics of the DRV Suspension",
    "symPyJSON": {
        "type": "and",
        "operands": [
            {
                "type": "or",
                "operands": [
                    {
                        "type": "variable",
                        "value": "Non-smoking for at least 3 months prior to selection"
                    },
                    {
                        "type": "variable",
                        "value": "Smoking no more than 10 cigarettes per day for at least 3 months prior to selection"
                    },
                    {
                        "type": "variable",
                        "value": "Smoking no more than 2 cigars per day for at least 3 months prior to selection"
                    },
                    {
                        "type": "variable",
                        "value": "Smoking no more than 2 pipes per day for at least 3 months prior to selection"
                    }
                ]
            },
            {
                "type": "variable",
                "value": "Normal weight as defined by a Body Mass Index (BMI) of 18.0 to 30.0 kg/m2, extremes included"
            },
            {
                "type": "variable",
                "value": "Able to comply with protocol requirements"
            },
            {
                "type": "variable",
                "value": "Healthy on the basis of a medical evaluation that includes a physical examination, medical history, electrocardiogram (ECG), vital signs, blood biochemistry, blood coagulation, hematology tests, and urinalysis"
            },
            {
                "type": "variable",
                "value": "Minimum age of 18 Years"
            },
            {
                "type": "variable",
                "value": "Maximum age of 55 Years"
            },
            {
                "type": "not",
                "operands": [
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Positive HIV 1 or HIV 2 test at screening"
                            },
                            {
                                "type": "variable",
                                "value": "History of significant skin disease such as rash, eruptions, drug allergies, food allergy, dermatitis, eczema, psoriasis, or urticaria"
                            },
                            {
                                "type": "variable",
                                "value": "History of allergy to drugs such as sulphonamides and penicillins"
                            },
                            {
                                "type": "variable",
                                "value": "Previously demonstrated clinically significant allergy or hypersensitivity to any excipients of the investigational medication administered in this trial"
                            },
                            {
                                "type": "variable",
                                "value": "Female subject of childbearing potential without use of effective nonhormonal birth control methods, or not willing to continue practicing these birth control methods for at least 30 days after the end of the treatment period"
                            },
                            {
                                "type": "variable",
                                "value": "Positive pregnancy test or breast feeding at screening"
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "symPyExpression": "And(Symbol('Able to comply with protocol requirements'), Symbol('Healthy on the basis of a medical evaluation that includes a physical examination, medical history, electrocardiogram (ECG), vital signs, blood biochemistry, blood coagulation, hematology tests, and urinalysis'), Symbol('Maximum age of 55 Years'), Symbol('Minimum age of 18 Years'), Symbol('Normal weight as defined by a Body Mass Index (BMI) of 18.0 to 30.0 kg/m2, extremes included'), Or(Symbol('Non-smoking for at least 3 months prior to selection'), Symbol('Smoking no more than 10 cigarettes per day for at least 3 months prior to selection'), Symbol('Smoking no more than 2 cigars per day for at least 3 months prior to selection'), Symbol('Smoking no more than 2 pipes per day for at least 3 months prior to selection')), Not(Or(Symbol('Female subject of childbearing potential without use of effective nonhormonal birth control methods, or not willing to continue practicing these birth control methods for at least 30 days after the end of the treatment period'), Symbol('History of allergy to drugs such as sulphonamides and penicillins'), Symbol('History of significant skin disease such as rash, eruptions, drug allergies, food allergy, dermatitis, eczema, psoriasis, or urticaria'), Symbol('Positive HIV 1 or HIV 2 test at screening'), Symbol('Positive pregnancy test or breast feeding at screening'), Symbol('Previously demonstrated clinically significant allergy or hypersensitivity to any excipients of the investigational medication administered in this trial'))))"
}